Judge Sides With Allergan On Eyelash-Growth Patent Claim

Law360, Los Angeles (March 8, 2013, 5:36 PM EST) -- A California federal judge on Tuesday granted partial summary judgment to Allergan Inc. on its claim that Cosmetic Alchemy LLC induced its customers to infringe Allergan’s patent on its popular eyelash growth drug Latisse, saying Allergan had proven its infringement allegations.

U.S. District Judge James V. Selna granted Allergan’s motion for partial summary judgment on its claim that Cosmetic Alchemy led its customers to infringe the patent, saying Allergan had shown that Cosmetic Alchemy had instructed customers to use its own eyelash growth drugs, LiLash and...
To view the full article, register now.